已收盘 02-06 16:00:00 美东时间
+0.660
+2.96%
今日重点评级关注:HC Wainwright & Co.:维持Assertio Holdings"买入"评级,目标价从3美元升至35美元;HC Wainwright & Co.:维持万达生物制药"买入"评级,目标价从20美元升至22美元
01-06 17:52
Raymond James analyst Justin Jenkins upgrades WaterBridge Infr (NYSE:WBI) from Outperform to Strong Buy and maintains the price target from $30 to $30.
01-06 01:44
U.S. stock futures were higher this morning, with the Dow futures gaining aroun...
2025-12-15 21:06
WaterBridge Infrastructure LLC press release (WBI): Q3 Revenue of $205.5M beats by $5.87M. Pro forma net loss for the third quarter of 2025 was $18.7 million. More on WaterBridge Infrastructure LLC Wa...
2025-11-13 06:16
今日重点评级关注:摩根大通:维持Cogent Biosciences"超配"评级,目标价从30美元升至44美元;Piper Sandler:维持Vital Energy"中性"评级,目标价从16美元升至30美元
2025-10-22 10:10
Janney Montgomery Scott analyst Michael Gaugler initiates coverage on WaterBridge Infr (NYSE:WBI) with a Neutral rating and announces Price Target of $24.
2025-10-21 19:17
Woodbois ( ($GB:WBI) ) just unveiled an update. Woodbois Limited, a company who...
2025-10-20 21:07
今日重点评级关注:Roth Capital:维持Cingulate"买入"评级,目标价从10美元升至17美元;JMP证券:维持BioCryst Pharma"跑赢大市"评级,目标价从17美元升至27美元
2025-10-16 10:43
重磅发声!美联储主席鲍威尔今夜将发表重要讲话;稀土概念股持续强势,CRML飙升超34%;特斯拉盘前跌约2.5%,美国将对公司近290万辆“全自动驾驶”汽车展开调查>>
2025-10-14 20:19
今日重点评级关注:花旗:维持Arcus Biosciences"买入"评级,目标价从47美元升至54美元;HC Wainwright & Co.:上调Karyopharm Therapeutics评级至"买入",目标价15美元
2025-10-14 09:56